n(1)-methylnicotinamide has been researched along with MPTP Neurotoxicity Syndrome in 1 studies
N(1)-methylnicotinamide: RN given refers to parent cpd
1-methylnicotinamide : A pyridinium ion comprising nicotinamide having a methyl group at the 1-position. It is a metabolite of nicotinamide which was initially considered to be biologically inactive but has emerged as an anti-thrombotic and anti-inflammatory agent.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rollema, H | 1 |
| Johnson, EA | 1 |
| Booth, RG | 1 |
| Caldera, P | 1 |
| Lampen, P | 1 |
| Youngster, SK | 1 |
| Trevor, AJ | 1 |
| Naiman, N | 1 |
| Castagnoli, N | 1 |
1 other study available for n(1)-methylnicotinamide and MPTP Neurotoxicity Syndrome
| Article | Year |
|---|---|
In vivo intracerebral microdialysis studies in rats of MPP+ analogues and related charged species.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Animals; Brain; Chemical | 1990 |